Literature DB >> 19421056

Role of the adaptor protein PDZK1 in controlling the HDL receptor SR-BI.

Olivier Kocher1, Monty Krieger.   

Abstract

PURPOSE OF REVIEW: Regulation of lipoprotein receptor activity influences lipoprotein metabolism, related physiology and pathophysiology. Adaptor proteins that bind to the LDL or HDL receptors apparently link these receptors to cellular components essential for their normal functioning. Here, we focus on the influence of PDZK1 on the HDL receptor scavenger receptor class B type I (SR-BI), with emphasis on the roles played by its individual PDZ domains, the impact in regulating HDL metabolism and the relevance for cardiovascular disease. RECENT
FINDINGS: PDZK1 plays an essential role in maintaining hepatic SR-BI levels and controlling HDL metabolism, protects against the development of atherosclerosis in a murine model and also mediates SR-BI-dependent regulation of endothelial cell biology by HDL, suggesting that PDZK1 plays multiple roles in normal physiology and may influence associated disorder. All four PDZ domains of PDZK1 appear necessary to promote normal hepatic expression, function and intracellular localization of SR-BI.
SUMMARY: SR-BI mediates several features of HDL metabolism and function, some of which depend on SR-BI's interaction with PDZK1. Exploration of the structure and function of PDZK1 and the mechanisms by which it controls SR-BI will provide additional insights into HDL metabolism and may provide the basis for new therapeutic modalities for cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19421056      PMCID: PMC2849150          DOI: 10.1097/MOL.0b013e32832aee82

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  64 in total

1.  Role of PDZK1 in membrane expression of renal brush border ion exchangers.

Authors:  R Brent Thomson; Tong Wang; Benjamin R Thomson; Luis Tarrats; Adriana Girardi; SueAnn Mentone; Manoocher Soleimani; Olivier Kocher; Peter S Aronson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-02       Impact factor: 11.205

2.  Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo.

Authors:  YuZhen Zhang; Jaqueline R Da Silva; Muredach Reilly; Jeffrey T Billheimer; George H Rothblat; Daniel J Rader
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

3.  Interaction with PDZK1 is required for expression of organic anion transporting protein 1A1 on the hepatocyte surface.

Authors:  Pijun Wang; Jin J Wang; Yansen Xiao; John W Murray; Phyllis M Novikoff; Ruth Hogue Angeletti; George A Orr; Debin Lan; David L Silver; Allan W Wolkoff
Journal:  J Biol Chem       Date:  2005-06-30       Impact factor: 5.157

4.  Regulation of SR-BI protein levels by phosphorylation of its associated protein, PDZK1.

Authors:  Toshiyuki Nakamura; Norihito Shibata; Takako Nishimoto-Shibata; Dongdong Feng; Mamoru Ikemoto; Kiyoto Motojima; Naoyuki Iso-O; Kazuhisa Tsukamoto; Masafumi Tsujimoto; Hiroyuki Arai
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-08       Impact factor: 11.205

5.  Fenofibrate induces a novel degradation pathway for scavenger receptor B-I independent of PDZK1.

Authors:  Debin Lan; David L Silver
Journal:  J Biol Chem       Date:  2005-04-18       Impact factor: 5.157

Review 6.  Regulation of SR-BI-mediated high-density lipoprotein metabolism by the tissue-specific adaptor protein PDZK1.

Authors:  Ayce Yesilaltay; Olivier Kocher; Attilio Rigotti; Monty Krieger
Journal:  Curr Opin Lipidol       Date:  2005-04       Impact factor: 4.776

7.  Cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor-BI mediate HDL-initiated signaling.

Authors:  Chatchawin Assanasen; Chieko Mineo; Divya Seetharam; Ivan S Yuhanna; Yves L Marcel; Margery A Connelly; David L Williams; Margarita de la Llera-Moya; Philip W Shaul; David L Silver
Journal:  J Clin Invest       Date:  2005-03-24       Impact factor: 14.808

Review 8.  Endothelial and antithrombotic actions of HDL.

Authors:  Chieko Mineo; Hiroshi Deguchi; John H Griffin; Philip W Shaul
Journal:  Circ Res       Date:  2006-06-09       Impact factor: 17.367

9.  Characterization of a new form of inherited hypercholesterolemia: familial recessive hypercholesterolemia.

Authors:  G Zuliani; M Arca; A Signore; G Bader; S Fazio; M Chianelli; S Bellosta; F Campagna; A Montali; M Maioli; A Pacifico; G Ricci; R Fellin
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-03       Impact factor: 8.311

10.  The scaffold protein PDZK1 undergoes a head-to-tail intramolecular association that negatively regulates its interaction with EBP50.

Authors:  David P LaLonde; Anthony Bretscher
Journal:  Biochemistry       Date:  2009-03-17       Impact factor: 3.162

View more
  42 in total

1.  PDZ domain-containing 1 (PDZK1) protein regulates phospholipase C-β3 (PLC-β3)-specific activation of somatostatin by forming a ternary complex with PLC-β3 and somatostatin receptors.

Authors:  Jung Kuk Kim; Ohman Kwon; Jinho Kim; Eung-Kyun Kim; Hye Kyung Park; Ji Eun Lee; Kyung Lock Kim; Jung Woong Choi; Seyoung Lim; Heon Seok; Whaseon Lee-Kwon; Jang Hyun Choi; Byoung Heon Kang; Sanguk Kim; Sung Ho Ryu; Pann-Ghill Suh
Journal:  J Biol Chem       Date:  2012-04-23       Impact factor: 5.157

2.  Noncanonical role of the PDZ4 domain of the adaptor protein PDZK1 in the regulation of the hepatic high density lipoprotein receptor scavenger receptor class B, type I (SR-BI).

Authors:  Kosuke Tsukamoto; Thomas E Wales; Kathleen Daniels; Rinku Pal; Ren Sheng; Wonhwa Cho; Walter Stafford; John R Engen; Monty Krieger; Olivier Kocher
Journal:  J Biol Chem       Date:  2013-05-17       Impact factor: 5.157

Review 3.  Hepatocyte polarity.

Authors:  Aleksandr Treyer; Anne Müsch
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

Review 4.  Scavenger receptor class B type I (SR-BI): a versatile receptor with multiple functions and actions.

Authors:  Wen-Jun Shen; Jie Hu; Zhigang Hu; Fredric B Kraemer; Salman Azhar
Journal:  Metabolism       Date:  2014-03-21       Impact factor: 8.694

5.  Role of sphingosine 1-phosphate in anti-atherogenic actions of high-density lipoprotein.

Authors:  Koichi Sato; Fumikazu Okajima
Journal:  World J Biol Chem       Date:  2010-11-26

6.  Novel mechanisms of regulation of the expression and transcriptional activity of hepatocyte nuclear factor 4α.

Authors:  Shangdong Guo; Hong Lu
Journal:  J Cell Biochem       Date:  2018-09-07       Impact factor: 4.429

7.  Carboxy-terminal deletion of the HDL receptor reduces receptor levels in liver and steroidogenic tissues, induces hypercholesterolemia, and causes fatal heart disease.

Authors:  Rinku Pal; Qingen Ke; German A Pihan; Ayce Yesilaltay; Marsha L Penman; Li Wang; Chandramohan Chitraju; Peter M Kang; Monty Krieger; Olivier Kocher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-09-30       Impact factor: 4.733

8.  A regulated complex of the scaffolding proteins PDZK1 and EBP50 with ezrin contribute to microvillar organization.

Authors:  David P LaLonde; Damien Garbett; Anthony Bretscher
Journal:  Mol Biol Cell       Date:  2010-03-17       Impact factor: 4.138

9.  Cellular cholesterol delivery, intracellular processing and utilization for biosynthesis of steroid hormones.

Authors:  Jie Hu; Zhonghua Zhang; Wen-Jun Shen; Salman Azhar
Journal:  Nutr Metab (Lond)       Date:  2010-06-01       Impact factor: 4.169

10.  The SR-BI partner PDZK1 facilitates hepatitis C virus entry.

Authors:  Nicholas S Eyre; Heidi E Drummer; Michael R Beard
Journal:  PLoS Pathog       Date:  2010-10-07       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.